Patents Assigned to Galderma S.A.
  • Device for dosing a product that is intended to be applied to the skin
    Patent number: 7727204
    Abstract: The present invention concerns a device for metering products intended to be applied to the skin, in particular pharmaceutical or cosmetic compositions. The invention relates more particularly to a device taking the form of an applicator stick, the graduations of which allow users to determine precisely the quantity of medication to be applied to the skin as a function of the surface area to be treated.
    Type: Grant
    Filed: December 2, 2004
    Date of Patent: June 1, 2010
    Assignee: Galderma S.A.
    Inventors: Sandrine Negrier, Dominique Ducrest
  • TOPICAL SKIN CARE COMPOSITION
    Publication number: 20100125057
    Abstract: A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide for the treatment of hyperpigmented skin conditions, such as melasma.
    Type: Application
    Filed: January 22, 2010
    Publication date: May 20, 2010
    Applicant: GALDERMA S.A.
    Inventors: Nancy Puglia, Jerry Roth, Rosario Ramirez
  • Foaming compositions for hair care
    Patent number: 7700081
    Abstract: The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: April 20, 2010
    Assignee: Galderma S.A.
    Inventors: Isabelle Preuilh, Anne-Emmanuelle Guise, Nathalie Willcox
  • Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
    Publication number: 20100029601
    Abstract: Topical application of a triple combination immixture of fluocinolone acetonide, tretinoin and hydroquinone is useful for the maintenance therapy of melasma to prevent hyperpigmentation recurrence or reduce the severity of the hyperpigmentation recurrence.
    Type: Application
    Filed: June 19, 2009
    Publication date: February 4, 2010
    Applicant: GALDERMA S.A.
    Inventor: Ivonne Arellano Mendoza
  • Preparation of amorolfine
    Publication number: 20100004442
    Abstract: Amorolfine base, which is a compound of formula (I): is improvedly prepared by: (i) contacting a compound of formula (II): with a Friedel-Crafts catalyst; and (ii) adding one equivalent of 2-halogeno-2-methylbutane, wherein the reaction mixture obtained in step (i) is cooled to a temperature from ?40° to ?60° C. prior to step (ii) and the Friedel-Craft catalyst is selected from the group consisting of gallium chloride, antimony pentafluoride, molybdenum pentachloride, indium chloride, antimony pentachloride.
    Type: Application
    Filed: June 22, 2009
    Publication date: January 7, 2010
    Applicant: GALDERMA S.A.
    Inventors: Beat Weber, Stefan Rosenberger
  • Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
    Publication number: 20090325914
    Abstract: Topical application of a triple combination immixture of fluocinolone acetonide, tretinoin and hydroquinone is useful for the maintenance therapy of melasma to prevent hyperpigmentation recurrence or reduce the severity of the hyperpigmentation recurrence.
    Type: Application
    Filed: June 19, 2009
    Publication date: December 31, 2009
    Applicant: GALDERMA S.A.,
    Inventor: Ivonne Arellano Mendoza
  • Petroleum jelly-free unguent compositions comprising vitamin D compounds and optionally steroidal anti-inflammatory agents
    Publication number: 20090298801
    Abstract: Novel compositions in petroleum jelly-free unguent form, in particular for topical application, contain a vitamin D compound and optionally an active agent of the family of steroidal anti-inflammatory agents.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 3, 2009
    Applicant: GALDERMA S.A.
    Inventors: Nathalie Willcox, Nathalie Barthez, Karine NADAU-FOURCADE, Claire MALLARD
  • Double compartment skincare products comprising avermectin/milbemycin compounds
    Publication number: 20090286866
    Abstract: Double compartment skincare products confine a first compartment containing an anhydrous composition including an active ingredient, and a second compartment, wherein the active ingredient is selected from among compounds of the avermectin family and compounds of the milbemycin family, and are useful as medicaments for the treatment and/or prevention of dermatological conditions/afflictions.
    Type: Application
    Filed: April 10, 2009
    Publication date: November 19, 2009
    Applicant: GALDERMA S.A.
    Inventors: Sandrine Segura-Orsoni, Fabienne Louis
  • Avermectin compounds and treatment of dermatological disorders in humans therewith
    Publication number: 20090281175
    Abstract: Compounds of the avermectin family or derivatives thereof, notably latidectin, are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea.
    Type: Application
    Filed: March 26, 2009
    Publication date: November 12, 2009
    Applicant: GALDERMA S.A.
    Inventors: Alexandre Kaoukhov, Cecile Cousin
  • Avermectin compounds and treatment of dermatological disorders in humans therewith
    Publication number: 20090264378
    Abstract: Compounds of the avermectin family or derivatives thereof, notably emamectins are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea.
    Type: Application
    Filed: March 26, 2009
    Publication date: October 22, 2009
    Applicant: GALDERMA S.A.
    Inventors: Alexandre Kaoukhov, Cecile Cousin
  • Milbemycin compounds and treatment of dermatological disorders in humans therewith
    Publication number: 20090264517
    Abstract: Compounds of the milbemycin family or derivatives thereof are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea.
    Type: Application
    Filed: March 26, 2009
    Publication date: October 22, 2009
    Applicant: GALDERMA S.A.
    Inventors: Alexandre Kaoukhov, Cecile Cousin
  • Milbemycin compounds and treatment of dermatological disorders in humans therewith
    Publication number: 20090264516
    Abstract: Compounds of the milbemycin family or derivatives thereof are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea.
    Type: Application
    Filed: March 26, 2009
    Publication date: October 22, 2009
    Applicant: GALDERMA S.A.
    Inventors: Alexandre Kaoukhov, Cecile Cousin
  • Administration of 6'-ethyl lepimectin, 6' -methyl lepimectin or derivatives thereof for treating dermatological disorders in humans
    Publication number: 20090258938
    Abstract: 6?-ethyl lepimectin, 6?-methyl lepimectin or derivatives thereof are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea.
    Type: Application
    Filed: March 26, 2009
    Publication date: October 15, 2009
    Applicant: GALDERMA S.A.,
    Inventors: Alexandre Kaoukhov, Cecile Cousin
  • Dermatological compositions comprising avermectin nanocapsules
    Publication number: 20090258065
    Abstract: Compositions and nanoemulsions containing lipid nanocapsules dispersed in a hydrophilic phase, such nanocapsules including at least one avermectin compound, are useful for the treatment of dermatological pathologies, e.g., rosacea.
    Type: Application
    Filed: April 10, 2009
    Publication date: October 15, 2009
    Applicant: GALDERMA S.A.
    Inventors: Lara Baudonnet, Claire Mallard
  • TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS
    Publication number: 20090252797
    Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
    Type: Application
    Filed: June 12, 2009
    Publication date: October 8, 2009
    Applicant: Galderma S.A.
    Inventors: Vincent MANETTA, Gary R. Watkins
  • AVERMECTIN/BENZOYL PEROXIDE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
    Publication number: 20090233996
    Abstract: Pharmaceutical/dermatological compositions containing at least one avermectin compound, e.g., ivermectin and benzoyl peroxide, are useful for treating afflictions of the skin, especially rosacea.
    Type: Application
    Filed: May 27, 2009
    Publication date: September 17, 2009
    Applicant: Galderma S.A.
    Inventors: ALEXANDRE KAOUKHOV, COLETTE PERNIN
  • AVERMECTIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS THEREWITH
    Publication number: 20090233877
    Abstract: Compounds of the natural avermectin family are formulated into pharmaceutical compositions useful for the treatment of dermatological conditions in humans, in particular rosacea.
    Type: Application
    Filed: March 20, 2009
    Publication date: September 17, 2009
    Applicant: GALDERMA S.A.
    Inventors: Alexandre KAOUKHOV, Cecile Cousin
  • Synergistically pro-penetrating solutions for ungual/peri-ungual dermatological/cosmetic applications
    Patent number: 7588753
    Abstract: Topically applicable dermatological/cosmetic compositions suited for ungual/peri-ungual administration for the treatment of a variety of pathologies, including fungal pathologies, such as onychomycosis, contain (a) at least one biologically active agent (e.g., antifungal) and (b) at least two of the pro-penetrating agents selected from the group consisting of urea, an organic acid and an ethoxydiglycol, the at least two-pro-penetrating agents respectively being present in effective amounts as to synergistically improve the ungual/peri-ungual bioavailability of the at least one biologically active agent.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: September 15, 2009
    Assignee: Galderma S.A.
    Inventors: Agnes Ferrandis, Sandrine Orsoni, Laurent Fredon
  • High stability aqueous gels comprising metronidazole and methods for the preparation thereof
    Publication number: 20090215849
    Abstract: A method for preparing highly stable aqueous gels based on metronidazole, well suited for treating such skin conditions as rosacea, acne and dermatitis, entails the successive steps of: (A) forming a solvent medium M comprising water and propylene glycol; (B) dissolving the metronidazole in this solvent medium M, and optionally diluting the medium obtained by addition of water, whereby a solution S of metronidazole is obtained; and thence (C) mixing the solution S obtained with a gelling polymer, in a sufficient amount to ensure gelling of the composition.
    Type: Application
    Filed: August 21, 2007
    Publication date: August 27, 2009
    Applicant: GALDERMA S.A.
    Inventors: Leila Zarif, Gerald Pedrassi, Alain Brzokewicz
  • Process of producing amorolfine base
    Publication number: 20090163711
    Abstract: An improved process of producing Amorolfine base, which is a compound of formula (I): said process including the steps of: (i) contacting a compound of formula (II): with a Friedel-Crafts catalyst at a temperature in the range of 20° to 30° C.; (ii) adding a 2-halogeno-2-methylbutane thereto, and wherein the reaction mixture obtained in step (i) is cooled to a temperature of from ?40° to ?60° C. prior to step (ii).
    Type: Application
    Filed: July 27, 2006
    Publication date: June 25, 2009
    Applicant: GALDERMA S.A.
    Inventors: Beat Weber, Stefan Rosenberger